Despite the advancements, several challenges remain in the field of cancer immunity:
Immune-related adverse events: Enhancing the immune response can sometimes lead to inflammation and damage to normal tissues. Resistance: Some tumors may develop resistance to immunotherapies over time. Heterogeneity: Tumors are often heterogeneous, meaning they contain different types of cells that may respond differently to immune attacks.
